基层医疗中直肠指检筛查前列腺癌的系统综述与荟萃分析
该系统综述与荟萃分析检索多个数据库至2016年6月,纳入7项研究共9241例同时接受直肠指检(DRE)和活检的患者,评估基层医疗中DRE筛查前列腺癌的诊断准确性。汇总敏感度为0.51(95%CI 0.36-0.67),特异度为0.59(95%CI 0.41-0.76),阳性预测值0.41(95%CI 0.31-0.52),阴性预测值0.64(95%CI 0.58-0.70),GRADE证据质量极低。鉴于支持其效力的证据严重不足,作者建议反对在基层医疗中常规使用DRE筛查前列腺癌。
要点
- 基层DRE筛查前列腺癌的汇总敏感度仅0.51,漏诊比例较高。
- 汇总特异度0.59,阳性预测值0.41,假阳性与假阴性均较常见。
- GRADE证据质量极低,不建议基层常规用DRE筛查前列腺癌。
核心结论
- 鉴于支持DRE筛查效力的证据严重不足,建议反对在基层医疗中常规进行DRE筛查前列腺癌。
研究设计与样本
- 系统综述与荟萃分析,检索MEDLINE、Embase、DARE、Cochrane CENTRAL、Cochrane系统综述数据库和CINAHL从建库至2016年6月。
- 最终纳入7项研究共9241例患者,所有分析患者均接受DRE和活检。
- 由6名评审员两两独立筛选文献并提取数据,采用逆方差荟萃分析计算汇总估计值。
- 使用QUADAS-2评估偏倚风险,GRADE评估证据质量。
主要发现
- 基层临床医生行DRE的汇总敏感度为0.51(95%CI 0.36-0.67;I2=98.4%)。
- 汇总特异度为0.59(95%CI 0.41-0.76;I2=99.4%)。
- 汇总阳性预测值为0.41(95%CI 0.31-0.52;I2=97.2%)。
- 汇总阴性预测值为0.64(95%CI 0.58-0.70;I2=95.0%)。
- GRADE评估的证据质量极低。
关键数值与推荐
- DRE筛查前列腺癌的汇总敏感度0.51(95%CI 0.36-0.67),特异度0.59(95%CI 0.41-0.76)。
- 汇总阳性预测值0.41(95%CI 0.31-0.52),阴性预测值0.64(95%CI 0.58-0.70)。
- GRADE证据质量评级为极低。
临床怎么用
- 不建议在基层医疗中常规使用DRE筛查前列腺癌。
- 临床决策时应考虑DRE筛查准确性有限且证据质量极低。
局限性
- 纳入研究间异质性极高(敏感度I2=98.4%,特异度I2=99.4%)。
- GRADE评估的证据质量极低。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Although the digital rectal examination (DRE) is commonly performed to screen for prostate cancer, there is limited data to support its use in primary care. This review and meta-analysis aims to evaluate the diagnostic accuracy of DRE in screening for prostate cancer in primary care settings. METHODS: We searched MEDLINE, Embase, DARE (Database of Abstracts of Reviews of Effects), Cochrane Central Register of Controlled Trials, Cochrane Database of Systematic Reviews, and CINAHL (Cumulative Index to Nursing and Allied Health Literature) from their inception to June 2016. Six reviewers, in pairs, independently screened citations for eligibility and extracted data. Pooled estimates were calculated for sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of DRE in primary care settings using an inverse-variance meta-analysis. We used QUADAS-2 (Quality Assessment of Diagnostic Accuracy Studies 2) and GRADE (Grades of Recommendation Assessment, Development, and Evaluation) guidelines to assess study risk of bias and quality. RESULTS: Our search yielded 8,217 studies, of which 7 studies with 9,241 patients were included after the screening process. All patients analyzed underwent both DRE and biopsy. Pooled sensitivity of DRE performed by primary care clinicians was 0.51 (95% CI, 0.36-0.67; I2 = 98.4%) and pooled specificity was 0.59 (95% CI, 0.41-0.76; I2 = 99.4%). Pooled PPV was 0.41 (95% CI, 0.31-0.52; I2 = 97.2%), and pooled NPV was 0.64 (95% CI, 0.58-0.70; I2 = 95.0%). The quality of evidence as assessed with GRADE was very low. CONCLUSION: Given the considerable lack of evidence supporting its efficacy, we recommend against routine performance of DRE to screen for prostate cancer in the primary care setting.
引用
- Naji L, Randhawa H, Sohani Z, et al. Digital Rectal Examination for Prostate Cancer Screening in Primary Care: A Systematic Review and Meta-Analysis. Ann Fam Med. 2018. PMID: 29531107. doi:10.1370/afm.2205
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。